Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes

Quality and duration of responses with mogamulizumab in cutaneous T‐cell lymphomas: Insights into long‐lasting outcomes

Pileri, Alessandro;Bernardelli, Andrea;Visco, Carlo;
2025-01-01

Abstract

Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes
2025
Sézary syndrome
mogamulizumab
mycosis fungoides
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1192412
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact